Asia Pacific Extremity Reconstruction Market Size, Share & Industry Trends Analysis Report By Material, By Product, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Extremity Reconstruction Market is expected to witness market growth of 7.4% CAGR during the forecast period (2022-2028).

The introduction and use of vacuum-assisted (sub-atmospheric) wound care has enabled the prolonged management of large, complex open wounds more feasible. The extra time enables for a clearer demarcation of non-viable tissues and numerous débridements before the final reconstruction. The extra time may also give the reconstructive surgeon a better understanding of the injured zone before performing the microsurgical technique. To reduce the danger of thrombosis, micro-vascular anastomoses must always be performed beyond the zone of injury. Following, this rule may eventually necessitate the utilization of a flap with a lengthy vascular pedicle, a vein graft, or the development of an arteriovenous loop. Though definitive reconstructive treatments can be postponed without a demonstrable increase in problems, in the case of open hardware or important systems such as blood arteries and peripheral nerves, healthcare professionals recommend early ultimate soft-tissue coverage.

Various reasons including rising economies, increased focus on the medical sector, and high healthcare awareness are contributing to the growth of the regional market. The elderly are more susceptible to orthopedic disorders, resulting in a big target population in the region, with Japan, China, and India giving the most. Additionally, considerable untapped potential, rising corporate interest in growing the footprint across the area, and continued R&D investments by key market players for enhanced creative items will fuel the market development. For instance, in April 2018, B. Braun opened five new manufacturing locations in Malaysia to increase the production of medical devices for pharmaceutical solutions, infusion therapy, and surgical instruments. The healthcare sector of the Asia-Pacific region is now actively investing in the growth of healthcare infrastructure.

The China market dominated the Asia Pacific Extremity Reconstruction Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $445.5 Million by 2028. The Japan market is anticipated to grow at a CAGR of 6.7% during (2022 - 2028). Additionally, The India market is expected to experience a CAGR of 8% during (2022 - 2028).

Based on Material, the market is segmented into Metallic, Ceramic, Polymeric, and Natural. Based on Product, the market is segmented into Upper Extremity and Lower Extremity. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), Integra LifeSciences Holdings Corporation, Medtronic PLC, ConMed Corporation, Acumed LLC, Skeletal Dynamics, LLC, Arthrex, Inc., and IDS GeoRadar s.r.l.(Hexagon AB)

Scope of the Study

Market Segments Covered in the Report:

By Material

• Metallic
• Ceramic
• Polymeric
• Natural

By Product

• Upper Extremity
• Lower Extremity

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Smith & Nephew PLC
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Johnson & Johnson (DePuy Synthes)
• Integra LifeSciences Holdings Corporation
• Medtronic PLC
• ConMed Corporation
• Acumed LLC
• Skeletal Dynamics, LLC
• Arthrex, Inc

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free